| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/11/1998 | WO1998039026A2 Methods of therapeutic administration of anti-cd40l compounds |
| 09/11/1998 | WO1998031795A3 Novel human metallothionein |
| 09/11/1998 | WO1998030692A3 Human endosulfine gene |
| 09/11/1998 | WO1998030687A3 Protein containing an srcr domain |
| 09/11/1998 | WO1998028424A3 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily |
| 09/11/1998 | WO1998020135A3 Protease-activatable pseudomonas exotoxin a-like proproteins |
| 09/11/1998 | CA2284083A1 Antigenic structural peptide, antigenic and immunogenic compounds and uses for detecting, preventing and treating an hcv infection |
| 09/11/1998 | CA2284078A1 A lymphocyte surface receptor that binds caml, nucleic acids encoding the same and methods of use thereof |
| 09/11/1998 | CA2283394A1 Methods and compositions for diagnosis and treatment of cancer |
| 09/11/1998 | CA2282830A1 Sp.alpha.: a scavenger receptor cysteine-rich domain-containing polypeptide, and monoclonal antibodies thereto |
| 09/11/1998 | CA2282760A1 Human chemokine receptor-like chemokine |
| 09/11/1998 | CA2282717A1 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products |
| 09/11/1998 | CA2282709A1 Protein kinase c inhibitor-like protein (ipkc-2) |
| 09/11/1998 | CA2281934A1 Use of preparations containing anti-cd44 antibodies for the treatment of certain tumours and for the supression of immune reactions |
| 09/11/1998 | CA2247799A1 Polynucleotides and polypeptides belonging to the uncoupling proteins family |
| 09/09/1998 | EP0863208A2 Histidine Kinase polypeptides, polynucleotides encluding the same and use thereof |
| 09/09/1998 | EP0863207A1 RNA dependent amidotransferase A from Staphylococcus Aureus |
| 09/09/1998 | EP0863204A1 Human cyclin i and gene encoding the same |
| 09/09/1998 | EP0863157A1 Anti-metakaryocyte monoclonal antibody 97A6 |
| 09/09/1998 | EP0863153A2 Foam proteins, monoclonal antibodies thereto, and their uses |
| 09/09/1998 | EP0862919A1 Remedy for hepatitides |
| 09/09/1998 | EP0862631A1 Luminal cholecystokinin-releasing factor |
| 09/09/1998 | EP0862630A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 09/09/1998 | EP0862629A1 Epithelial membrane protein-1 |
| 09/09/1998 | EP0862628A1 Receptor and nucleic acid molecule encoding said receptor |
| 09/09/1998 | EP0862627A1 Neuropeptide y-y5 receptor |
| 09/09/1998 | EP0862618A1 Chitin synthase 1 |
| 09/09/1998 | EP0862584A1 Production of antibodies, and medical uses involving antibodies |
| 09/09/1998 | EP0862461A1 Methods of treating established colitis using antibodies against il-12 |
| 09/09/1998 | EP0862460A1 Methods of reducing apolipoprotein e4-induced inhibition of neuron remodeling |
| 09/09/1998 | EP0862459A1 Uses of tfpi inhibitor for treatment of cancer |
| 09/09/1998 | EP0862447A1 Generating d-peptides: methods and compositions |
| 09/09/1998 | EP0862444A1 Treatment of cardiomyopathy by removal of autoantibodies |
| 09/09/1998 | CN1192779A Monkey monoclonal antibodies specific to human b. 7.1 and/or B7.2 primatized forms, pharmaceutical compositions |
| 09/09/1998 | CN1192695A High affinity human monoclonal antibodies specific for RSV F-protein |
| 09/09/1998 | CN1192693A Therapeutic agent and autoimmune diseases |
| 09/08/1998 | US5804566 Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides |
| 09/08/1998 | US5804561 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 09/08/1998 | US5804558 Containing disulfide bonds; useful as preservatives and in preventing, treating or ameliorating viral or microbial infections in animals and plants |
| 09/08/1998 | US5804440 A deoxypolynucleotide encoding heavy chanin immunologlobulin variable region amino acid residue sequence portion of humans monoclonal antibody which is used in immunotherapy and diagnosis |
| 09/08/1998 | US5804428 Fibrin sealant compositions and methods for utilizing same |
| 09/08/1998 | US5804419 Encoded by a polynucleotide sequence; forming hybridization complex with nucleic acid material of sample; detecting complex. |
| 09/08/1998 | US5804399 Incubation; measuring effect of composition on kinase or polynucleotide encoding the kinase |
| 09/08/1998 | US5804394 Monoclonal antibody from hybridoma cell line bp-2280 |
| 09/08/1998 | US5804393 Analyzing insecticidal activity; test kit. |
| 09/08/1998 | US5804392 For detection and measurement of soluble endothelial protein c receptor |
| 09/08/1998 | US5804391 Elimination of rheumatoid factor interference using anti-FD antibodies |
| 09/08/1998 | US5804381 Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof |
| 09/08/1998 | US5804378 Test kit including primers for amplification, reagents for hybridization |
| 09/08/1998 | US5804376 Nucleotide and amino acid sequences; expression vector; genetically engineered host cells; diagnostic tests |
| 09/08/1998 | US5804200 Parasitic nematode proteins and vaccines |
| 09/08/1998 | US5804198 Vaccines against disease caused by pathogenic pilus-forming bacteria |
| 09/08/1998 | US5804187 Modified antibodies with human milk fat globule specificity |
| 09/08/1998 | US5804160 Transplanting xenogeneic hematopoietic tissue into mouse or rat, recovering immune cells, selecting for anti-hepatitis virus reactivity |
| 09/08/1998 | US5804159 Antiplasma animal model |
| 09/07/1998 | CA2199455A1 Cloned lysophosphatidic acid receptors |
| 09/03/1998 | WO1998038513A1 Signal enhancement of bispecific antibody-polymer probe for immunoassay use |
| 09/03/1998 | WO1998038324A2 Chimeric cell-surface receptors that undergo antigen-induced association |
| 09/03/1998 | WO1998038312A1 Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof |
| 09/03/1998 | WO1998038311A1 T1/st2-receptor ligand iii |
| 09/03/1998 | WO1998038310A1 A tm4sf human tumor-associated antigen |
| 09/03/1998 | WO1998038307A1 Novel human transmembrane 4 superfamily protein |
| 09/03/1998 | WO1998038305A1 Physiologically active protein originating in mammals |
| 09/03/1998 | WO1998038283A1 Methods for selecting germ-line competent cells in chicken embryos, and the use of the cells in the production of chimeras |
| 09/03/1998 | WO1998038216A1 Cell surface molecule mediating cell adhesion and signal transmission |
| 09/03/1998 | WO1998038212A2 Chimeric polypeptides containing chemokine domains |
| 09/03/1998 | WO1998037916A1 Novel lipid compounds and compositions containing same used for the transfer of at least an active substance, in particular a polynucleotide, in a target cell and therapeutic use |
| 09/03/1998 | WO1998037914A1 Remedies for hepatitis |
| 09/03/1998 | WO1998037913A1 Lymphocyte activation inhibitors |
| 09/03/1998 | WO1998037757A1 Pluripotent cells having disrupted intrinsic genes |
| 09/03/1998 | CA2283107A1 A tm4sf human tumor-associated antigen |
| 09/03/1998 | CA2282791A1 Methods for selecting germ-line competent cells in chicken embryos, and the use of the cells in the production of chimeras |
| 09/03/1998 | CA2282736A1 Novel human transmembrane 4 superfamily protein |
| 09/03/1998 | CA2282631A1 Lymphocyte activation inhibitors |
| 09/03/1998 | CA2282557A1 Physiologically active protein originating in mammals |
| 09/03/1998 | CA2282401A1 T1/st2-receptor ligand iii |
| 09/03/1998 | CA2252942A1 Novel lipid compounds and compositions containing same used for the transfer of at least an active substance, in particular a polynucleotide, in a target cell and therapeutic use |
| 09/03/1998 | CA2252629A1 Remedies for hepatitis |
| 09/03/1998 | CA2252625A1 Chimeric cell-surface receptors that undergo antigen-induced association |
| 09/03/1998 | CA2247072A1 Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof |
| 09/03/1998 | CA2198988A1 P28 bap31 a bcl-2 associated protein and use thereof for the modulation of apoptosis |
| 09/02/1998 | EP0861900A1 Immunological detection of prions |
| 09/02/1998 | EP0861899A1 LicA polypeptides from Sreptococcus pneumoniae |
| 09/02/1998 | EP0861898A1 Rat Cathepsin K polynucleotide & polypeptide sequence |
| 09/02/1998 | EP0861895A2 aroE shikimate 5 dehydrogenase from Staphylococcus Aureus |
| 09/02/1998 | EP0861893A2 High level expression of immunoglobulin polypeptides |
| 09/02/1998 | EP0861892A1 Stress protein epitopes |
| 09/02/1998 | EP0861891A1 Compounds for modulating cell negative regulations and biological applications thereof |
| 09/02/1998 | EP0861890A1 LicC polypeptides from Streptococcus pneumoniae |
| 09/02/1998 | EP0861889A1 LicD2 polypeptides from Streptococcus pneumoniae |
| 09/02/1998 | EP0861664A2 Vaccine against Lyme disease |
| 09/02/1998 | EP0861440A1 Recombinant proteins having multiple disulfide bonds and thiol-substituted conjugates thereof |
| 09/02/1998 | EP0861326A1 Hybrid factor viii with modified activity |
| 09/02/1998 | EP0861320A1 Sequestrin |
| 09/02/1998 | EP0861268A1 Inhibitory and non-inhibitory antigen binding polypeptides against human p450 enzymes |
| 09/02/1998 | EP0861261A1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 09/02/1998 | EP0861091A1 Immunotoxin containing a disulfide-stabilized antibody fragment |
| 09/02/1998 | EP0861090A1 Tumor associated internalizing antigens and methods for targeting therapeutic agents |
| 09/02/1998 | EP0716659A4 Epiligrin, an epithelial ligand for integrins |
| 09/02/1998 | EP0705276B1 Prostaglandin receptor fp and dna encoding it |